During the past decade, Westchester Medical Center conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 18 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 10 clinical trials were completed. i.e. 25.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westchester Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials, followed by "New York Medical College" with 7 trials sponsored, "Alexion" with 3 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westchester Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Glaxo Wellcome" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Abbott" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Westchester Medical Center" are "HIV Infections" (8 trials), "Coronary Artery Disease" (5 trials), "Heart Failure" (5 trials), "Endometrial Clear Cell Adenocarcinoma" (3 trials) and "Endometrial Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Westchester Medical Center" in a lesser frequency.

Most popular intervention types in "Westchester Medical Center" are "Drug" (55 trials), "Device" (26 trials), "Other" (21 trials), "Biological" (15 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Quality-of-Life Assessment" (7 trials), "Zidovudine" (7 trials), "Carboplatin" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Westchester Medical Center" are 97 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Westchester Medical Center". undefined are not yet recruiting, 23 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Westchester Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Westchester Medical Center, 8 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".

Westchester Medical Center has several departments that took part in Clinical trials: "Westchester Hosp / New York Med College / Pediatrics" - 2 trials, "WMCHealth Heart and Vascular Institute Kingston Division of Cardiology" - 2 trials